MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
- A8688 TAK-715Summary: p38 MAPK inhibitor
- A8689 PD 169316Target: p38Summary: P38 MAPK inhibitor
- B3261 RO4987655Summary: MEK inhibitor
- B3275 TCS JNK 5aTarget: JNKSummary: JNK2 and JNK3 inhibitor
- B1285 SB 203580 hydrochlorideTarget: p38Summary: Specific p38-MAPKs inhibitor
- B2227 BI-D18701 CitationTarget: p90 S6KSummary: P90 RSK inhibitor,ATP-competitive and cell-permeable
- B1405 GW5074Summary: C-Raf inhibitor,potent and selective
- B1406 SB5908851 CitationSummary: Potent B-Raf inhibitor
- B1260 CC-401Summary: JNK inhibitor,ATP-competitive
- B1621 TAK-733Target: MEKSummary: MEK allosteric site inhibitor